Skip to Content

Join the 'Emend' group to help and get support from people like you.

Emend News

Managing Motion Sickness

Posted 30 Jun 2017 by Drugs.com

FRIDAY, June 30, 2017 – Your friends are excited to ride that monster roller coaster, but just looking at it makes you queasy. Is there anything you can do to quell your motion sickness so you can join in the fun? If you suffer from motion sickness, there are some ways to deal with it, one doctor says, though riding roller coasters isn't likely an activity you'll ever love. Motion sickness can occur in cars, on planes, boats, trains and amusement park rides, and even when sitting too close to a movie theater screen or using a virtual reality device. Motion sickness occurs when the brain gets mixed information. The brain combines input from the eyes with information from the parts of the body touching the ground, and then links that information with the vestibular system in the ears that controls balance. If these things don't match up, motion sickness can occur. "Some people can feel ... Read more

Related support groups: Nausea/Vomiting, Ativan, Lorazepam, Benadryl, Promethazine, Diphenhydramine, Zofran, Phenergan, Meclizine, Reglan, Ondansetron, Marinol, Dramamine, Compazine, Metoclopramide, Motion Sickness, Prochlorperazine, Scopolamine, Perphenazine, Thorazine

FDA Approves Pediatric Indication for Emend (aprepitant) Capsules in Combination with Other Antiemetic Agents

Posted 2 Sep 2015 by Drugs.com

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Emend (aprepitant) capsules, a substance P/neurokinin 1 (NK1) receptor antagonist. With this expanded indication, Emend capsules are now approved for use in combination with other antiemetic agents in patients 12 years of age and older and patients less than 12 years who weigh at least 30 kg (approximately 66 pounds) for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin, as well as for the prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC). Emend has not been ... Read more

Related support groups: Nausea/Vomiting - Chemotherapy Induced, Emend, Aprepitant

Ask a Question

Further Information

Related Condition Support Groups

Nausea / Vomiting - Postoperative, Nausea / Vomiting - Chemotherapy Induced

Emend Patient Information at Drugs.com